News
Team recommends melanoma screening in CLL
- Author:
- HT Staff
Patients with chronic lymphocytic leukemia (CLL) should be routinely monitored for melanoma, according to researchers. A study of 470 CLL patients...
News
Frequent BCCs linked to blood cancers
- Author:
- HT Staff
New research suggests people who develop frequent cases of basal cell carcinoma (BCC) have an increased risk of leukemias, lymphomas, and other...
News
Comprehensive sequencing informs treatment for MM
- Author:
- HT Staff
A comprehensive RNA and DNA sequencing platform can guide treatment decisions for late-stage and drug-resistant multiple myeloma (MM), according...
News
Tool identifies potential treatment for resistant MM
- Author:
- HT Staff
Researchers say they have developed a computational platform that can be used to identify optimal treatments for multiple myeloma (MM). Using...
News
FDA approves mogamulizumab for MF, SS
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has approved mogamulizumab-kpkc (Poteligeo®) for the treatment of adults with relapsed or refractory...
News
Health Canada approves emicizumab
- Author:
- HT Staff
Health Canada has approved emicizumab (Hemlibra®) for use as routine prophylaxis to prevent or reduce bleeding episodes in hemophilia A patients...
News
Drug could be repurposed for T-ALL
- Author:
- HT Staff
Venetoclax might improve the treatment of certain patients with T-cell acute lymphoblastic leukemia (T-ALL), according to preclinical research...
News
FDA grants fast track designation to dilanubicel
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has granted fast track designation to dilanubicel (NLA101) for use in patients with high-risk...
News
A new way to expand HSCs for UCB transplant
- Author:
- HT Staff
Researchers say they have discovered a new approach to expand hematopoietic stem cells (HSCs) from umbilical cord blood (UCB). The team...
News
Treatment guidelines for CAR T-cell therapy
- Author:
- HT Staff
Researchers have developed treatment guidelines for pediatric patients receiving chimeric antigen receptor (CAR) T-cell therapy. The guidelines...
News
FDA advises against azithromycin use in allo-HSCT recipients
- Author:
- HT Staff
The US Food and Drug Administration (FDA) is warning against long-term use of azithromycin (Zithromax, Zmax) in patients who undergo allogeneic...
News
Company stops development of drug for MM
- Author:
- HT Staff
MorphoSys AG has decided to stop developing MOR202 as a treatment for multiple myeloma (MM). However, MorphoSys said it will complete the ongoing...
News
Company narrows focus of development for tazemetostat
- Author:
- HT Staff
Epizyme, Inc., has announced its decision to stop developing tazemetostat for use as monotherapy or in combination with prednisolone for patients...
News
Orphan designation recommended for PCM-075
- Author:
- HT Staff
The European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has recommended that PCM-075 receive orphan drug designation as a...
News
Work explains link between hypoxia and thrombosis
- Author:
- HT Staff
Researchers say they have discovered how hypoxia increases the risk of thrombosis. The team noted that the cellular response to hypoxia is...